Biomedical subjects

Michael Chow

Publications and source records attributed to Michael Chow.

5 recordsLinked to original sources

PubMed2003

Laboratory and field experiments used to identify Canis lupus var. familiaris active odor signature chemicals from drugs, explosives, and humans.

This paper describes the use of headspace solid-phase microextraction (SPME) combined with gas chromatography to identify the signature odors that law enforcement-certified detector dogs alert to when searching for drugs, explosives, and humans. Background information is provided on the many types of detector dog available and specific samples highlighted in this paper are the drugs cocaine and 3,4-methylenedioxy- N-methylamphetamine (MDMA or Ecstasy), the explosives TNT and C4, and human remains. Studies include the analysis and identification of the headspace "fingerprint" of a variety of samples, followed by completion of double-blind dog trials of the individual components in an attempt to isolate and understand the target compounds that dogs alert to. SPME-GC/MS has been demonstrated to have a unique capability for the extraction of volatiles from the headspace of forensic specimens including drugs and explosives and shows great potential to aid in the investigation and understanding of the complicated process of canine odor detection. Major variables evaluated for the headspace SPME included fiber chemistry and a variety of sampling times ranging from several hours to several seconds and the resultant effect on ratios of isolated volatile components. For the drug odor studies, the CW/DVB and PDMS SPME fibers proved to be the optimal fiber types. For explosives, the results demonstrated that the best fibers in field and laboratory applications were PDMS and CW/DVB, respectively. Gas chromatography with electron capture detector (GC/ECD) and mass spectrometry (GC/MS) was better for analysis of nitromethane and TNT odors, and C-4 odors, respectively. Field studies with detector dogs have demonstrated possible candidates for new pseudo scents as well as the potential use of controlled permeation devices as non-hazardous training aids providing consistent permeation of target odors.

Animals↗

PubMed2003

Commissioning and clinical implementation of a sliding gantry CT scanner installed in an existing treatment room and early clinical experience for precise tumor localization.

The primary objective of the present study is to demonstrate that a unique computed tomography (CT)-linear accelerator combination can be used to reduce uncertainties caused by organ motion and setup inaccuracy. The acceptance, commissioning, and clinical implementation of a sliding gantry CT scanner installed in an existing linear accelerator room are reported in this paper. A Siemens CT scanner was installed directly opposite to an existing accelerator. The scanner is movable on a pair of horizontal rails mounted parallel to the longitudinal axis of the treatment couch replaced with a carbon fiber tabletop. Acceptance and commissioning of the CT scanner were verified with phantom studies. For clinical implementation, quality assurance (QA) procedures have been instituted to ensure the integrity of the CT gantry axis alignment and the accuracy of its movement using a phantom designed in house. A clinical example employing the CT-Linac combination to correct the isocenter positioning caused by organ motion and setup inaccuracy was presented for a prostate irradiation. Dose calculations were performed to study the effects on tumor coverage without the adjustments of the isocenter. A summary of the isocenter adjustments for the first 30 patients is also presented. The geometric accuracy of the CT scanner is < or =1 mm. An isocenter deviation of > or =2 mm from the original plan can be detected. For the clinical example of a prostate patient, the average movement of the prostate gland was found to be approximately 3mm in the anterior-posterior (AP/PA) direction and 5 mm in the cephalic-caudal direction. Variations in the isocenter position may result in underdosage of the PTV if correction is not made for the change in the isocenter position. Our experience with the first 30 patients indicates that while the left-right adjustment of the isocenter is minimal, in the AP/PA direction, about 33% of treatments required an adjustment of 3-5 mm, and about 18% required a 5.1-mm to 10-mm adjustment. In the caudal-cephalic direction, about 26% required an adjustment of 3-5 mm, and 8% required a 5.1-mm to 10-mm adjustment. Retrofitting a CT scanner in an existing linear accelerator room requires careful planning and well-coordinated efforts from all personnel involved. Special QA procedures are needed to ensure the mechanical integrity and imaging accuracy of the CT scanner. A CT scan of the patient prior to irradiation provides valuable information on organ motion. Any deviations from treatment plan can be corrected before dose delivery. Significant deviation from the planning isocenter may occur due to daily variations in the rectal filling. The CT-Linac combination has significant implications for the treatment of prostate cancer.

Humans↗

PubMed2002

Vasospasm.

Explore the source record for details and available documents.

Animals↗

PubMed2002

Cavernous malformation of the hypoglossal nerve: case report and review of the literature.

OBJECTIVE: To describe a patient who presented with a hypoglossal nerve palsy caused by a cavernous malformation, review the literature on cavernous malformations associated with cranial nerves and the differential diagnosis of hypoglossal palsy. RESULTS: Partial resection of the lesion was achieved and the diagnosis of cavernous malformation proven histologically. CONCLUSIONS: Involvement of a cranial nerve by a cavernous malformation is very uncommon and the facial nerve is the example most frequently reported. This case report adds another possible site for this rare occurrence.

Adult↗

PubMed2002

Endothelin receptor antagonists and cerebral vasospasm: an update.

THIS REVIEW UPDATES: the current status of endothelin receptor antagonists in the treatment of cerebral vasospasm. Recent preclinical and clinical studies are reviewed, as well as clinical trials for other medical indications. Some of the newer endothelin receptor antagonists are also examined.

Animals↗